Michael G. White, M.D., MSc
Department of Colon & Rectal Surgery, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Colon & Rectal Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2016 | The University of Chicago, Chicago, IL, USA, MS, Public Health Science |
| 2012 | Jefferson Medical College, Philadelphia, PA, USA, MD, Medicine |
| 2006 | Princeton University, Princeton, NJ, USA, AB, Physics |
Postgraduate Training
| 2020-2021 | Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2019-2022 | Clinical Fellowship, Complex General Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2014-2016 | Research Residency, The University of Chicago, Chicago, IL |
| 2012-2019 | Clinical Residency, General Surgery, The University of Chicago, Chicago, IL |
Experience & Service
Administrative Appointments/Responsibilities
Administrative Research Fellow, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Administrative Chief Resident, Department of Department of General Surgery, The University of Chicago, Chicago, IL, 2018 - 2019
Administrative Research Resident, The University of Chicago, Chicago, IL, 2015 - 2016
Honors & Awards
| 2022 | Eva Lotzova Basic/Translational Research Award, The University of Texas MD Anderson Cancer Center |
| 2022 | Harold C. and Mary L. Dailey Endowed Research Fellowship Award, The University of Texas MD Anderson Cancer Center |
| 2021 | Eva Lotzova Basic/Translational Research Award, The University of Texas MD Anderson Cancer Center |
| 2019 | Trauma Unit Surgical Resident of the Year, Cook County Hospital |
| 2019 | Robert Baker Golden Apple Award for Excellence in Teaching, The University of Chicago Department of Surgery |
| 2018 | University of Chicago General Surgery Academic Achievement Award, The University of Chicago |
| 2017 | University of Chicago General Surgery Academic Achievement Award, The University of Chicago |
| 2016 | Best Basic Science Presentation, Society of Surgical Oncology |
| 2015 | University of Chicago General Surgery Academic Achievement Award, The University of Chicago |
| 2014 | University of Chicago General Surgery Academic Achievement Award, The University of Chicago |
| 2014 | Clinical Research Abstract Contest Winner, American Thyroid Association |
| 2013 | University of Chicago General Surgery Academic Achievement Award, The University of Chicago |
Selected Publications
Peer-Reviewed Articles
- Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt RG, Daniele JR, Titus M, McQuade JL, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Segura RL, Liu Q, Borthwick MS, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu LE, Mahendra M, Ma X, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long GV, Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan TP, Marszalek JR, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
- Bhutiani N, Cox DM, Robinson KA, Kim BJ, Mansfield PF, Fournier KF, White MG. Stapled Versus Hand-Sewn Anastomosis in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. J Gastrointest Surg. e-Pub 2022. PMID: 35676459.
- Cass SH, Ajami NJ, White MG. The Microbiome: the Link to Colorectal Cancer and Research Opportunities. Curr Treat Options Oncol 23(5):631-644, 2022. e-Pub 2022. PMID: 35254596.
- Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart M, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg. e-Pub 2022. PMID: 35373260.
- Pourmaleki M, Jones CJ, Ariyan CE, Zeng Z, Pirun M, Navarrete DA, Li Y, Zhang M, Nandakumar S, Campos C, Nadeem S, Klimstra DS, Temple-Oberle CF, Brenn T, Lipson EJ, Schenk KM, Stein JE, Taube JM, White MG, Traweek R, Wargo JA, Kirkwood JM, Gasmi B, Goff SL, Corwin AD, McDonough E, Ginty F, Callahan MK, Schietinger A, Socci ND, Mellinghoff IK, Hollmann TJ. Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma. Cancer Immunol Res 10(3):303-313, 2022. PMID: 35013003.
- White MG, Badgwell B. Oncologic Components of HIPEC: Key Question : In patients with gastric or colorectal adenocarcinoma metastatic to the peritoneum, does cytoreductive surgery (CRS) plus hyperthermic intraperitoneal perfusion with chemotherapy (HIPEC) prolong survival or increase the risk of complications relative to CRS alone?. Ann Surg Oncol. e-Pub 2022. PMID: 34994900.
- Zhang LM, Schuitevoerder D, White MG, Feldt S, Krishnan P, Hyman N, Shogan BD. Combined mechanical and oral antibiotic bowel preparation is associated with prolonged recurrence-free survival following surgery for colorectal cancer. J Surg Oncol 124(7):1106-1114, 2021. e-Pub 2021. PMID: 34310702.
- White MG, Morgan RB, Drazer MW, Eng OS. Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. J Gastrointest Surg 25(12):3258-3264, 2021. e-Pub 2021. PMID: 34506017.
- Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
- Applewhite M, White MG, Kaplan E, Angelos P, Grogan R. Failure to Intervene on Thyroid Cancer. World J End Surg 13(2):10002-1405, 2021.
- White MG, Badgwell BD. Laparoscopic Heated Intraperitoneal Chemotherapy in the Treatment of Carcinomatosis of Gastric Adenocarcinoma Origin. J Clin Med 10(20), 2021. e-Pub 2021. PMID: 34682880.
- Sloane RAS, White MG, Witt RG, Banerjee A, Davies MA, Han G, Burton E, Ajami N, Simon JM, Bernatchez C, Haydu LE, Tawbi HA, Gershenwald JE, Keung E, Ross M, McQuade J, Amaria RN, Wani K, Lazar AJ, Woodman SE, Wang L, Andrews MC, Wargo JA. Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771465.
- White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 28(8):4615-4622, 2021. e-Pub 2021. PMID: 33415562.
- White MG, Tzeng CD. ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma. Ann Surg Oncol 28(8):4623-4624, 2021. e-Pub 2021. PMID: 33507452.
- Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan MAW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Alou MT, Yonekura S, Roh W, Spencer CN, Curbelo IF, Vence L, Reuben A, Johnson S, Arora R, Morad G, Lastrapes M, Baruch EN, Little L, Gumbs C, Cooper ZA, Prieto PA, Wani K, Lazar AJ, Tetzlaff MT, Hudgens CW, Callahan MK, Adamow M, Postow MA, Ariyan CE, Gaudreau PO, Nezi L, Raoult D, Mihalcioiu C, Elkrief A, Pezo RC, Haydu LE, Simon JM, Tawbi HA, McQuade J, Hwu P, Hwu WJ, Amaria RN, Burton EM, Woodman SE, Watowich S, Diab A, Patel SP, Glitza IC, Wong MK, Zhao L, Zhang J, Ajami NJ, Petrosino J, Jenq RR, Davies MA, Gershenwald JE, Futreal PA, Sharma P, Allison JP, Routy B, Zitvogel L, Wargo JA. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat Med 27(8):1432-1441, 2021. e-Pub 2021. PMID: 34239137.
- White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic Partial Segment VIII Resection. Ann Surg Oncol 28(3):1513, 2021. e-Pub 2020. PMID: 32761429.
- White MG, Eng OS. Response to Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy". Br J Cancer 124(6):1179-1180, 2021. e-Pub 2020. PMID: 33318658.
- White MG, Schulte JJ, Xue L, Berger Y, Schuitevoerder D, Vining CC, Kindler HL, Husain A, Turaga KK, Eng OS. Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy. Br J Cancer 124(3):564-566, 2021. e-Pub 2020. PMID: 33100328.
- White MG, Szczepaniak Sloane R, Witt RG, Reuben A, Gaudreau PO, Andrews MC, Feng N, Johnson S, Class CA, Bristow C, Wani K, Hudgens C, Nezi L, Manzo T, De Macedo MP, Hu J, Davis R, Jiang H, Prieto P, Burton E, Hwu P, Tawbi H, Gershenwald J, Lazar AJ, Tetzlaff MT, Overwijk W, Woodman SE, Cooper ZA, Marszalek JR, Davies MA, Heffernan TP, Wargo JA. Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma. Oncoimmunology 10(1):1992880, 2021. e-Pub 2021. PMID: 34777916.
- Parker KG, White MG, Cipriani NA. Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis. Head Neck Pathol 14(4):1067-1079, 2020. e-Pub 2020. PMID: 32358715.
- White MG, Kothari A, Ikoma N, Murphy MB, Song S, Ajani J, Mansfield P, Badgwell B. Factors Associated with Resection and Survival After Laparoscopic HIPEC for Peritoneal Gastric Cancer Metastasis. Ann Surg Oncol 27(13):4963-4969, 2020. e-Pub 2020. PMID: 32648181.
- White MG, Tran Cao HS. ASO Author Reflections: The Role of the Robot in Liver Surgery: An Evolution in Progress. Ann Surg Oncol 27(Suppl 3):897-898, 2020. e-Pub 2020. PMID: 32813200.
- White MG, Wargo JA. Gut Microbes' Impact on Oncogenic Drivers: Location Matters. Mol Cell 79(6):878-880, 2020. PMID: 32946762.
- Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer 126(11):2525-2533, 2020. e-Pub 2020. PMID: 32282073.
- Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer 126(11):2571-2576, 2020. e-Pub 2020. PMID: 32282059.
- Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer 126(11):2534-2540, 2020. e-Pub 2020. PMID: 32282070.
- White MG, Cipriani NA, Abdulrasool L, Kaplan S, Aschebrook-Kilfoy B, Angelos P, Kaplan EL, Grogan RH, Onel K. Radiation-Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease-Free Survival. Thyroid 26(8):1053-60, 2016. PMID: 27279587.
- White MG, Nagar S, Aschebrook-Kilfoy B, Jasmine F, Kibriya MG, Ahsan H, Angelos P, Kaplan EL, Grogan RH. Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome-wide Methylation Analysis. Ann Surg Oncol 23(7):2302-9, 2016. e-Pub 2016. PMID: 26979305.